Clinical Trial Update: Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of IZN-6N4 oral rinse to prevent oral mucositis in patients undergoing treatment for head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• IZN-6N4 Oral Rinse (IZN-6N4)

Snippet

Sponsor: Izun Pharma Ltd | Conditions: Oral Mucositis | Phase 2 | Status: COMPLETED